CD8αα expression marks terminally differentiated human CD8+ T cells expanded in chronic viral infection

Frontiers in Immunology

Volumn 4, Issue AUG, 2013, Pages

  Walker, L J ^a,b   Marrinan, E ^a   Muenchhoff, M ^a   Ferguson, J ^a   Kloverpris, H ^a,c,d   Cheroutre, H ^e   Barnes, E ^a,f   Goulder, P ^a   Klenerman, Paul ^a,f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^f NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

CD8 ; CD8+ T cells; Hepatitis B; Hepatitis C; HIV 1

Indexed keywords

ANTIBODY; CD161 ANTIGEN; CD8ALPHA ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; TETRAMER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; YOUNG ADULT;

EID: 84883697504     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00223     Document Type: Article

References (47)

1. Huang Y, Park Y, Wang-Zhu Y, Larange A, Arens R, Bernardo I, et al. Mucosal memory CD8+ T cells are selected in the periphery by an MHC class I molecule. Nat Immunol (2011) 12:1086-95. doi:10.1038/ni.2106
2. Moebius U, Kober G, Griscelli AL, Hercend T, Meuer SC. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur J Immunol (1991) 21:1793-800. doi:10.1002/eji.1830210803
3. Cheroutre H, Lambolez F. Doubting the TCR coreceptor function of CD8alphaalpha. Immunity (2008) 28:149-59. doi:10.1016/j.immuni.2008.01.005
4. Madakamutil LT, Christen U, Lena CJ, Wang-Zhu Y, Attinger A, Sundarrajan M, et al. CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. Science (2004) 304:590-3. doi:10.1126/science.1092316
5. Walker LJ, Kang Y-H, Smith MO, Tharmalingham H, Ramamurthy N, Fleming VM, et al. Human MAIT and CD8a+a cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2012) 119:422-33. doi:10.1182/blood-2011-05-353789
6. Konno A, Okada K, Mizuno K, Nishida M, Nagaoki S, Toma T, et al. CD8alpha alpha memory effector T cells descend directly from clonally expanded CD8alpha +beta high TCRalpha beta T cells in vivo. Blood (2002) 100:4090-7. doi:10.1182/blood-2002-04-1136
7. Schmitz JE, Forman MA, Lifton MA, Concepción O, Reimann KA, Crumpacker CS, et al. Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals. Blood (1998) 92:198-206.
8. Werwitzke S, Tiede A, Jacobs R, Zielinska-Skowronek M, Buyny S, Schmidt RE, et al. CD8alpha+beta(low) effector T cells in systemic lupus erythematosus. Scand J Immunol (2008) 67:501-8. doi:10.1111/j.1365-3083.2008.02093.x
9. Kawabata K, Nagasawa M, Morio T, Okawa H, Yata J. Decreased alpha/beta heterodimer among CD8 molecules of peripheral blood T cells in Wiskott-Aldrich syndrome. Clin Immunol Immunopathol (1996) 81:129-35. doi:10.1006/clin.1996.0168
10. Watanabe N, De Rosa SC, Cmelak A, Hoppe R, Herzenberg LA, Roederer M. Long-term depletion of naive T cells in patients treated for Hodgkin's disease. Blood (1997) 90:3662-72.
11. Wooldridge L, van den Berg HA, Glick M, Gostick E, Laugel B, Hutchinson SL, et al. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J Biol Chem (2005) 280:27491-501. doi:10.1074/jbc.M500555200
12. Veillette A, Bookman MA, Horak EM, Bolen JB. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell (1988) 55:301-8. doi:10.1016/0092-8674(88)90053-0
13. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A (1996) 93:4102-7. doi:10.1073/pnas.93.9.4102
14. Alexander-Miller MA. Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection. Cell Immunol (2000) 201:58-62. doi:10.1006/cimm.1999.1632
15. Wooldridge L, Lissina A, Cole DK, van den Berg HA, Price DA, Sewell AK. Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology (2009) 126:147-64. doi:10.1111/j.1365-2567.2008.02848.x
16. Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem (2007) 282:23799-810. doi:10.1074/jbc.M700976200
17. Kerry SE, Buslepp J, Cramer LA, Maile R, Hensley LL, Nielsen AI, et al. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. J Immunol (2003) 171:4493-503.
18. Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity (2003) 18:255-64. doi:10.1016/S1074-7613(03)00019-0
19. Sedlik C, Dadaglio G, Saron MF, Deriaud E, Rojas M, Casal SI, et al. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J Virol (2000) 74:5769-75. doi:10.1128/JVI.74.13.5769-5775.2000
20. Walker LJ, Sewell AK, Klenerman P. T cell sensitivity and the outcome of viral infection. Clin Exp Immunol (2010) 159:245-55. doi:10.1111/j.1365-2249.2009.04047.x
21. Iglesias MC, Almeida JR, Fastenackels S, van Bockel DJ, Hashimoto M, Venturi V, et al. Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood (2011) 118:2138-49. doi:10.1182/blood-2011-01-328781
22. Leishman AJ, Naidenko OV, Attinger A, Koning F, Lena CJ, Xiong Y, et al. T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL. Science (2001) 294:1936-9. doi:10.1126/science.1063564
23. Renard V, Romero P, Vivier E, Malissen B, Luescher IF. CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding. J Exp Med (1996) 184:2439-44. doi:10.1084/jem.184.6.2439
24. Karaki S, Tanabe M, Nakauchi H, Takiguchi M. Beta-chain broadens range of CD8 recognition for MHC class I molecule. J Immunol (1992) 149:1613-8.
25. Cawthon AG, Alexander-Miller MA. Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity. J Immunol (2002) 169:3492-8.
26. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GMA, Papagno L, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med (2002) 8:379-85. doi:10.1038/nm0402-379
27. High KP, Akbar AN, Nikolich-Zugich J. Translational research in immune senescence: assessing the relevance of current models. Semin Immunol (2012) 24:373-82. doi:10.1016/j.smim.2012.04.007
28. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol (2004) 2:e20. doi:10.1371/journal.pbio.0020020
29. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine (2006) 24:1159-69. doi:10.1016/j.vaccine.2005.08.105
30. Hakim FT, Gress RE. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens (2007) 70:179-89. doi:10.1111/j.1399-0039.2007.00891.x
31. Aspinall R, Del Giudice G, Effros RB, Grubeck-Loebenstein B, Sambhara S. Challenges for vaccination in the elderly. Immun Ageing (2007) 4:9. doi:10.1186/1742-4933-4-9
32. Lindstrom TM, Robinson WH. Rheumatoid arthritis: a role for immunosenescence? J Am Geriatr Soc (2010) 58:1565-75. doi:10.1111/j.1532-5415.2010.02965.x
33. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gerontol (2007) 42:432-7. doi:10.1016/j.exger.2006.12.003
34. Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PTF, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med (2008) 205:2111-24. doi:10.1084/jem.20072076
35. Liu Y, Xiong Y, Naidenko OV, Liu J-H, Zhang R, Joachimiak A, et al. The crystal structure of a TL/CD8alphaalpha complex at 2.1 A resolution: implications for modulation of T cell activation and memory. Immunity (2003) 18:205-15. doi:10.1016/S1074-7613(03)00027-X
36. Weber DA, Attinger A, Kemball CC, Wigal JL, Pohl J, Xiong Y, et al. Peptide-independent folding and CD8 alpha alpha binding by the nonclassical class I molecule, thymic leukemia antigen. J Immunol (2002) 169:5708-14.
37. Attinger A, Devine L, Wang-Zhu Y, Martin D, Wang J-H, Reinherz EL, et al. Molecular basis for the high affinity interaction between the thymic leukemia antigen and the CD8alphaalpha molecule. J Immunol (2005) 174:3501-7.
38. Devine L, Rogozinski L, Naidenko OV, Cheroutre H, Kavathas PB. The complementarity-determining region-like loops of CD8 alpha interact differently with beta 2-microglobulin of the class I molecules H-2Kb and thymic leukemia antigen, while similarly with their alpha 3 domains. J Immunol (2002) 168:3881-6.
39. Walker LJ, Smith M, Khan Y, Oo Y, Barnes E. 707 CD8αα T cells: a novel lineage enriched in the liver In chronic HCV J Hepatol (2010) 52(Suppl 1):S275. doi:10.1016/S0168-8278(10)60709-X
40. Billerbeck E, Kang Y-H, Walker L, Lockstone H, Grafmueller S, Fleming V, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A (2010) 107:3006-11. doi:10.1073/pnas.0914839107
41. Gangadharan D, Lambolez F, Attinger A, Wang-Zhu Y, Sullivan BA, Cheroutre H. Identification of pre- and post-selection TCRalphabeta+ intraepithelial lymphocyte precursors in the thymus. Immunity (2006) 25:631-41. doi:10.1016/j.immuni.2006.08.018
42. Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol (2011) 186:2672-80. doi:10.4049/jimmunol.1002653
43. Dock JN, Effros RB. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Dis (2011) 2:382-97.
44. Terabe M, Tagaya Y, Zhu Q, Granger L, Roederer M, Waldmann TA, et al. IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cells. J Immunol (2008) 180:7276-86.
45. Ma LJ, Acero LF, Zal T, Schluns KS. Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8alphaalpha IELs. J Immunol (2009) 183:1044-54. doi:10.4049/jimmunol.0900420
46. McNicol A-M, Bendle G, Holler A, Matjeka T, Dalton E, Rettig L, et al. CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR. Eur J Immunol (2007) 37:1634-41. doi:10.1002/eji.200636900
47. Werwitzke S, Tiede A, Drescher BE, Schmidt RE, Witte T. CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes. Clin Exp Immunol (2003) 133:334-43. doi:10.1046/j.1365-2249.2003.02226.x